Ranitidine hydrochloride and Desloratadine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine hydrochloride (ranitidine hydrochloride) and Desloratadine (desloratadine). Common drug interactions include abdominal pain among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine hydrochloride and Desloratadine. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Desloratadine?

Desloratadine has active ingredients of desloratadine. It is often used in allergies. eHealthMe is studying from 4,207 Desloratadine users. Check the latest studies of Desloratadine.

On Aug, 02, 2026

25 people who take Ranitidine hydrochloride and Desloratadine together, and have interactions are studied.

Ranitidine hydrochloride and Desloratadine drug interactions.

What are the common drug interactions of Ranitidine Hydrochloride and Desloratadine, by gender? *:

female:

Abdominal pain
Nausea (feeling of having an urge to vomit)
Pain
Abdominal pain upper
Arthropathy
Asthenia (weakness)
Back pain
C-reactive protein increased
Contusion (a type of hematoma of tissue in which capillaries)
Dyslipidaemia (abnormal amount of lipids)

male:

Blood creatinine increased
C-reactive protein decreased
Pneumonia
Productive cough
Pyrexia (fever)
Sepsis (a severe blood infection that can lead to organ failure and death)
Upper respiratory tract infection

What are the common drug interactions of Ranitidine Hydrochloride and Desloratadine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Foot deformity (functional disability of foot)
Abdominal pain
Nausea (feeling of having an urge to vomit)
Pain
Vomiting
Abdominal pain upper
Arthropathy
Asthenia (weakness)
Back pain
C-reactive protein increased

60+:

Pyrexia (fever)
Diarrhoea
Pneumonia
Productive cough
Sepsis (a severe blood infection that can lead to organ failure and death)
Upper respiratory tract infection
Anaemia (lack of blood)
Communication disorder (speech and language disorder)
Cough
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 36.00%
High Blood Cholesterol: 9 people, 36.00%
Lung Cancer - Non-Small Cell (lung cancer): 8 people, 32.00%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 5 people, 20.00%
High Blood Pressure: 4 people, 16.00%
Diarrhea: 4 people, 16.00%
Type 2 Diabetes: 3 people, 12.00%
Regurgitation (expulsion of material): 3 people, 12.00%
Rashes (redness): 3 people, 12.00%
Prostate Cancer: 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Desloratadine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously